{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:53:50Z","timestamp":1771062830548,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["735-63221055"],"award-info":[{"award-number":["735-63221055"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["735-63221434"],"award-info":[{"award-number":["735-63221434"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324122006017"],"award-info":[{"award-number":["JCYJ20210324122006017"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110555","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T10:29:45Z","timestamp":1688207385000},"page":"110555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Axitinib attenuates the progression of liver fibrosis by restoring mitochondrial function"],"prefix":"10.1016","volume":"122","author":[{"given":"Hailong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruotong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fubo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-3422","authenticated-orcid":false,"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110555_b0005","unstructured":"Q.W. Shurong Ren, Qizhen Yue, Yanli Zhang, Bei Zhang Withdrawal Notice: Cryptotanshinone Suppresses Liver Fibrosis by Attenuating Epithelial-Mesenchymal Transition through Targeting Hedgehog Pathway, Anticancer Agents Med Chem (2020)."},{"issue":"7","key":"10.1016\/j.intimp.2023.110555_b0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"10.1016\/j.intimp.2023.110555_b0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.intimp.2023.110555_b0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.intimp.2023.110555_b0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.intimp.2023.110555_b0030","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5152\/tjg.2020.20139","article-title":"Diagnosis of liver fibrosis in patients with hepatitis B-related liver disease using ultrasound with wave-number domain attenuation coefficient","volume":"31","author":"He","year":"2020","journal-title":"Turk J Gastroenterol"},{"issue":"4","key":"10.1016\/j.intimp.2023.110555_b0035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","article-title":"Mechanisms of liver fibrosis resolution","volume":"63","author":"Tacke","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.intimp.2023.110555_b0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.intimp.2023.110555_b0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev-biochem-062917-012341","article-title":"Defining Adult Stem Cells by Function, not by Phenotype","volume":"87","author":"Clevers","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.intimp.2023.110555_b0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","article-title":"Matrix metalloproteinases and liver fibrosis","volume":"68\u201369","author":"Roeb","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.intimp.2023.110555_b0055","doi-asserted-by":"crossref","unstructured":"M. Phaosri, S. Jantrapirom, M.N. Takuathung, N. Soonthornchareonnon, S. Sireeratawong, P. Buacheen, P. Pitchakarn, W. Nimlamool, S. Potikanond, Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells Through the Inhibition of the TGF-beta1-Induced SMAD2\/3 Signaling Pathway, Int J Mol Sci 20(24) (2019).","DOI":"10.3390\/ijms20246314"},{"issue":"3","key":"10.1016\/j.intimp.2023.110555_b0060","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110555_b0065","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1096\/fj.201801749RRR","article-title":"Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.intimp.2023.110555_b0070","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s11010-022-04369-5","article-title":"TGF-beta activates NLRP3 inflammasome by an autocrine production of TGF-beta in LX-2 human hepatic stellate cells","volume":"477","author":"Kang","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.intimp.2023.110555_b0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fphar.2019.00431","article-title":"Interaction Mechanisms Between the NOX4\/ROS and RhoA\/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2023.110555_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13071-018-3223-8","article-title":"NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-kappaB","volume":"12","author":"Zhang","year":"2019","journal-title":"Parasit Vectors"},{"issue":"9","key":"10.1016\/j.intimp.2023.110555_b0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrc3339","article-title":"Aiding and abetting roles of NOX oxidases in cellular transformation","volume":"12","author":"Block","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.intimp.2023.110555_b0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.redox.2015.09.003","article-title":"Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells","volume":"6","author":"Forkink","year":"2015","journal-title":"Redox Biol"},{"issue":"9","key":"10.1016\/j.intimp.2023.110555_b0095","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/CAD.0000000000000924","article-title":"Modulation of oxidative stress\/antioxidative defence in human serum treated by four different tyrosine kinase inhibitors","volume":"31","author":"Mihajlovic","year":"2020","journal-title":"Anticancer Drugs"},{"issue":"10","key":"10.1016\/j.intimp.2023.110555_b0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrd4592","article-title":"Dissecting fibrosis: therapeutic insights from the small-molecule toolbox","volume":"14","author":"Nanthakumar","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.intimp.2023.110555_b0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.semcancer.2020.03.005","article-title":"Old drugs, new uses: Drug repurposing in hematological malignancies","volume":"68","author":"Kale","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.intimp.2023.110555_b0110","unstructured":"D.J.S.J. Curtis R Chong New uses for old drugs, Nature (2007)."},{"issue":"8","key":"10.1016\/j.intimp.2023.110555_b0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.intimp.2023.110555_b0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1078155220975825","article-title":"A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide","volume":"27","author":"Amare","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"10.1016\/j.intimp.2023.110555_b0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/dom.12648","article-title":"Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion","volume":"18","author":"Hansen","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.intimp.2023.110555_b0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.tips.2018.07.006","article-title":"Metformin as an Anticancer Agent","volume":"39","author":"Vancura","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"17","key":"10.1016\/j.intimp.2023.110555_b0135","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMc1911668","article-title":"Transfusion Timing and Volume in African Children with Severe Anemia","volume":"381","author":"Maitland","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.intimp.2023.110555_b0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/op600280g","article-title":"Development of an effective palladium removal process for VEGF oncology candidate AG13736 and a simple, efficient screening technique for scavenger reagent identification","volume":"12","author":"Flahive","year":"2008","journal-title":"Organic Process Research & Development"},{"issue":"1","key":"10.1016\/j.intimp.2023.110555_b0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of organ fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.intimp.2023.110555_b0150","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbadis.2012.06.008","article-title":"Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease","volume":"1832","author":"Beyer","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.intimp.2023.110555_b0155","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1136\/annrheumdis-2013-203729","article-title":"Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors","volume":"72","author":"Maurer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2023.110555_b0160","first-page":"300","article-title":"New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials","volume":"6","author":"Qu","year":"2015","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.intimp.2023.110555_b0165","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.intimp.2023.110555_b0170","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","volume":"46","author":"Tugues","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110555_b0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08923973.2016.1263860","article-title":"Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl4) via anti-inflammatory and antioxidant mechanism","volume":"39","author":"Mohammadalipour","year":"2017","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.intimp.2023.110555_b0180","unstructured":"R.U.y.N. Nieto, Hepatic stellate cells and oxidative stress, Revista espanola de enfermedades digestivas 99(4) (2007) 223-230."},{"key":"10.1016\/j.intimp.2023.110555_b0185","article-title":"Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose","volume":"12","author":"Yang","year":"2021","journal-title":"Inhibiting Apoptosis and Modulating Overall Metabolism, Front Pharmacol"},{"key":"10.1016\/j.intimp.2023.110555_b0190","doi-asserted-by":"crossref","first-page":"2452848","DOI":"10.1155\/2020\/2452848","article-title":"Withaferin A Exerts Preventive Effect on Liver Fibrosis through Oxidative Stress Inhibition in a Sirtuin 3-Dependent Manner","volume":"2020","author":"Gu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.intimp.2023.110555_b0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mito.2011.01.010","article-title":"The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis","volume":"11","author":"Huttemann","year":"2011","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.intimp.2023.110555_b0200","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.intimp.2023.110555_b0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jnutbio.2009.01.011","article-title":"Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress","volume":"21","author":"Wolf","year":"2010","journal-title":"J Nutr Biochem"},{"issue":"9","key":"10.1016\/j.intimp.2023.110555_b0210","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1111\/jcmm.13743","article-title":"Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10.1016\/j.intimp.2023.110555_b0215","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd.2018.149","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.intimp.2023.110555_b0220","doi-asserted-by":"crossref","unstructured":"S.G. Boaru, E. Borkham-Kamphorst, L. Tihaa, U.H.a.R. Weiskirchen, Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease, Journal of Inflammation 9 (2012) 49.","DOI":"10.1186\/1476-9255-9-49"},{"issue":"22","key":"10.1016\/j.intimp.2023.110555_b0225","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.3390\/ijms222212413","article-title":"MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs","volume":"22","author":"Ge","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7427","key":"10.1016\/j.intimp.2023.110555_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2023.110555_b0235","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:20:18Z","timestamp":1736432418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923008780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":47,"alternative-id":["S1567576923008780"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110555","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axitinib attenuates the progression of liver fibrosis by restoring mitochondrial function","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110555"}}